Literature DB >> 22331897

Structural basis for mutual relief of the Rac guanine nucleotide exchange factor DOCK2 and its partner ELMO1 from their autoinhibited forms.

Kyoko Hanawa-Suetsugu1, Mutsuko Kukimoto-Niino, Chiemi Mishima-Tsumagari, Ryogo Akasaka, Noboru Ohsawa, Shun-ichi Sekine, Takuhiro Ito, Naoya Tochio, Seizo Koshiba, Takanori Kigawa, Takaho Terada, Mikako Shirouzu, Akihiko Nishikimi, Takehito Uruno, Tomoya Katakai, Tatsuo Kinashi, Daisuke Kohda, Yoshinori Fukui, Shigeyuki Yokoyama.   

Abstract

DOCK2, a hematopoietic cell-specific, atypical guanine nucleotide exchange factor, controls lymphocyte migration through ras-related C3 botulinum toxin substrate (Rac) activation. Dedicator of cytokinesis 2-engulfment and cell motility protein 1 (DOCK2ELMO1) complex formation is required for DOCK2-mediated Rac signaling. In this study, we identified the N-terminal 177-residue fragment and the C-terminal 196-residue fragment of human DOCK2 and ELMO1, respectively, as the mutual binding regions, and solved the crystal structure of their complex at 2.1-Å resolution. The C-terminal Pro-rich tail of ELMO1 winds around the Src-homology 3 domain of DOCK2, and an intermolecular five-helix bundle is formed. Overall, the entire regions of both DOCK2 and ELMO1 assemble to create a rigid structure, which is required for the DOCK2ELMO1 binding, as revealed by mutagenesis. Intriguingly, the DOCK2ELMO1 interface hydrophobically buries a residue which, when mutated, reportedly relieves DOCK180 from autoinhibition. We demonstrated that the ELMO-interacting region and the DOCK-homology region 2 guanine nucleotide exchange factor domain of DOCK2 associate with each other for the autoinhibition, and that the assembly with ELMO1 weakens the interaction, relieving DOCK2 from the autoinhibition. The interactions between the N- and C-terminal regions of ELMO1 reportedly cause its autoinhibition, and binding with a DOCK protein relieves the autoinhibition for ras homolog gene family, member G binding and membrane localization. In fact, the DOCK2ELMO1 interface also buries the ELMO1 residues required for the autoinhibition within the hydrophobic core of the helix bundle. Therefore, the present complex structure reveals the structural basis by which DOCK2 and ELMO1 mutually relieve their autoinhibition for the activation of Rac1 for lymphocyte chemotaxis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22331897      PMCID: PMC3295310          DOI: 10.1073/pnas.1113512109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Can we infer peptide recognition specificity mediated by SH3 domains?

Authors:  Gianni Cesareni; Simona Panni; Giuliano Nardelli; Luisa Castagnoli
Journal:  FEBS Lett       Date:  2002-02-20       Impact factor: 4.124

2.  Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex.

Authors:  Enrico Brugnera; Lisa Haney; Cynthia Grimsley; Mingjian Lu; Scott F Walk; Annie-Carole Tosello-Trampont; Ian G Macara; Hiten Madhani; Gerald R Fink; Kodimangalam S Ravichandran
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

3.  DOCK2 regulates Rac activation and cytoskeletal reorganization through interaction with ELMO1.

Authors:  Terukazu Sanui; Ayumi Inayoshi; Mayuko Noda; Eiko Iwata; Jens V Stein; Takehiko Sasazuki; Yoshinori Fukui
Journal:  Blood       Date:  2003-06-26       Impact factor: 22.113

4.  DOCK2 is essential for antigen-induced translocation of TCR and lipid rafts, but not PKC-theta and LFA-1, in T cells.

Authors:  Terukazu Sanui; Ayumi Inayoshi; Mayuko Noda; Eiko Iwata; Masahiro Oike; Takehiko Sasazuki; Yoshinori Fukui
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

5.  Multiple factors confer specific Cdc42 and Rac protein activation by dedicator of cytokinesis (DOCK) nucleotide exchange factors.

Authors:  Kiran Kulkarni; Jing Yang; Ziguo Zhang; David Barford
Journal:  J Biol Chem       Date:  2011-05-24       Impact factor: 5.157

6.  CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration.

Authors:  T L Gumienny; E Brugnera; A C Tosello-Trampont; J M Kinchen; L B Haney; K Nishiwaki; S F Walk; M E Nemergut; I G Macara; R Francis; T Schedl; Y Qin; L Van Aelst; M O Hengartner; K S Ravichandran
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

7.  Non-adherent cell-specific expression of DOCK2, a member of the human CDM-family proteins.

Authors:  H Nishihara; S Kobayashi; Y Hashimoto; F Ohba; N Mochizuki; T Kurata; K Nagashima; M Matsuda
Journal:  Biochim Biophys Acta       Date:  1999-11-11

8.  Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration.

Authors:  Y Fukui; O Hashimoto; T Sanui; T Oono; H Koga; M Abe; A Inayoshi; M Noda; M Oike; T Shirai; T Sasazuki
Journal:  Nature       Date:  2001-08-23       Impact factor: 49.962

9.  Zizimin1, a novel Cdc42 activator, reveals a new GEF domain for Rho proteins.

Authors:  Nahum Meller; Mohammad Irani-Tehrani; William B Kiosses; Miguel A Del Pozo; Martin A Schwartz
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

10.  Dock180 and ELMO1 proteins cooperate to promote evolutionarily conserved Rac-dependent cell migration.

Authors:  Cynthia M Grimsley; Jason M Kinchen; Annie-Carole Tosello-Trampont; Enrico Brugnera; Lisa B Haney; Mingjian Lu; Qi Chen; Doris Klingele; Michael O Hengartner; Kodi S Ravichandran
Journal:  J Biol Chem       Date:  2003-11-24       Impact factor: 5.157

View more
  29 in total

1.  ClipR-59 interacts with Elmo2 and modulates myoblast fusion.

Authors:  Yingmin Sun; Wenying Ren; Jean-François Côté; Philip W Hinds; Xiaoxiang Hu; Keyong Du
Journal:  J Biol Chem       Date:  2015-01-08       Impact factor: 5.157

2.  ELMO recruits actin cross-linking family 7 (ACF7) at the cell membrane for microtubule capture and stabilization of cellular protrusions.

Authors:  Yoran Margaron; Nadine Fradet; Jean-François Côté
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

3.  Variants in DOCK3 cause developmental delay and hypotonia.

Authors:  Kimberly Wiltrout; Alejandro Ferrer; Ingrid van de Laar; Kazuhiko Namekata; Takayuki Harada; Eric W Klee; Michael T Zimmerman; Margot A Cousin; Jennifer L Kempainen; Dusica Babovic-Vuksanovic; Marjon A van Slegtenhorst; Coranne D Aarts-Tesselaar; Rhonda E Schnur; Marisa Andrews; Marwan Shinawi
Journal:  Eur J Hum Genet       Date:  2019-04-11       Impact factor: 4.246

4.  DOCK2 and DOCK5 act additively in neutrophils to regulate chemotaxis, superoxide production, and extracellular trap formation.

Authors:  Mayuki Watanabe; Masao Terasawa; Kei Miyano; Toyoshi Yanagihara; Takehito Uruno; Fumiyuki Sanematsu; Akihiko Nishikimi; Jean-François Côté; Hideki Sumimoto; Yoshinori Fukui
Journal:  J Immunol       Date:  2014-10-22       Impact factor: 5.422

Review 5.  Epidermal activation of the small GTPase Rac1 in psoriasis pathogenesis.

Authors:  Mårten C G Winge; M Peter Marinkovich
Journal:  Small GTPases       Date:  2017-05-04

6.  DOCK2 Promotes Pleural Fibrosis by Modulating Mesothelial to Mesenchymal Transition.

Authors:  Guoqing Qian; Oluwaseun Adeyanju; Saptarshi Roy; Christudas Sunil; Ann Jeffers; Xia Guo; Mitsuo Ikebe; Steven Idell; Torry A Tucker
Journal:  Am J Respir Cell Mol Biol       Date:  2022-02       Impact factor: 6.914

7.  Dedicator of cytokinesis 8 interacts with talin and Wiskott-Aldrich syndrome protein to regulate NK cell cytotoxicity.

Authors:  Hyoungjun Ham; Sabrice Guerrier; JungJin Kim; Renee A Schoon; Erik L Anderson; Michael J Hamann; Zhenkun Lou; Daniel D Billadeau
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

8.  Essential role of Elmo1 in Dock2-dependent lymphocyte migration.

Authors:  Catherine Stevenson; Gonzalo de la Rosa; Christopher S Anderson; Patrick S Murphy; Tara Capece; Minsoo Kim; Michael R Elliott
Journal:  J Immunol       Date:  2014-05-12       Impact factor: 5.422

9.  TP Atlas: integration and dissemination of advances in Targeted Proteins Research Program (TPRP)-structural biology project phase II in Japan.

Authors:  Takao Iwayanagi; Sei Miyamoto; Takeshi Konno; Hisashi Mizutani; Tomohiro Hirai; Yasumasa Shigemoto; Takashi Gojobori; Hideaki Sugawara
Journal:  J Struct Funct Genomics       Date:  2012-05-29

10.  Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.

Authors:  Austin M Dulak; Petar Stojanov; Shouyong Peng; Michael S Lawrence; Cameron Fox; Chip Stewart; Santhoshi Bandla; Yu Imamura; Steven E Schumacher; Erica Shefler; Aaron McKenna; Scott L Carter; Kristian Cibulskis; Andrey Sivachenko; Gordon Saksena; Douglas Voet; Alex H Ramos; Daniel Auclair; Kristin Thompson; Carrie Sougnez; Robert C Onofrio; Candace Guiducci; Rameen Beroukhim; Zhongren Zhou; Lin Lin; Jules Lin; Rishindra Reddy; Andrew Chang; Rodney Landrenau; Arjun Pennathur; Shuji Ogino; James D Luketich; Todd R Golub; Stacey B Gabriel; Eric S Lander; David G Beer; Tony E Godfrey; Gad Getz; Adam J Bass
Journal:  Nat Genet       Date:  2013-03-24       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.